Effectiveness and gastrointestinal tolerability during conversion and titration with once-daily OROS® hydromorphone extended release in opioid-tolerant patients with chronic low back pain

PURPOSE: To describe the efficacy and safety of hydromorphone extended-release tablets (OROS hydromorphone ER) during dose conversion and titration. PATIENTS AND METHODS: A total of 459 opioid-tolerant adults with chronic moderate to severe low back pain participated in an open-label, 2- to 4-week c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hale, Martin E, Nalamachu, Srinivas R, Khan, Arif, Kutch, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645948/
https://www.ncbi.nlm.nih.gov/pubmed/23658495
http://dx.doi.org/10.2147/JPR.S39980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645948/
https://www.ncbi.nlm.nih.gov/pubmed/23658495
http://dx.doi.org/10.2147/JPR.S39980

Ejemplares similares